BridgeMD
New treatment option for Heart Transplant Rejection
Official title Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients
ClinicalTrials.gov ID: NCT05732779
What this study is testing
- What it's testing
- We will conduct a two-group randomized controlled trial to examine the eMocha DOT intervention with pediatric HT recipients.In this population, medication nonadherence remains a primary cause of late acute rejection (LAR) episodes, increased number of hospitalizations, graft failure, and patient mortality. Herein, we propose an innovative approach to promote medication adherence and improve patient and graft outcomes.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 10 to 21
You may be able to join if
- Eligible participants are 10-21 years of age
- Have received a heart transplant and are followed participating pediatric heart transplant centers
- English-speaking or Spanish-speaking
- Own a smart-phone or have access to the mobile app through other devices
- Are willing to receive information through it
You likely can't join if
- Those with cognitive impairments will not be eligible for enrollment due to inability to provide informed assent
See the full eligibility criteria
- Eligible participants are 10-21 years of age
- Have received a heart transplant and are followed participating pediatric heart transplant centers
- English-speaking or Spanish-speaking
- Own a smart-phone or have access to the mobile app through other devices
- Are willing to receive information through it
- Have a MLVI score of greater than 2.0 over the last year
- Those with cognitive impairments will not be eligible for enrollment due to inability to provide informed assent
The study team makes the final eligibility decision.
Where it's taking place
- Coral Gables, Florida, United States
- Gainesville, Florida, United States
- Hollywood, Florida, United States
- Tallahassee, Florida, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 10 years to 21 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Coral Gables, Florida, United States; Gainesville, Florida, United States; Hollywood, Florida, United States; Tallahassee, Florida, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.